Lance Armstrong stepped down as chairman of Livestrong Wednesday, following the publication of evidence of his use of performance-enhancing drugs, the Star Tribune reported.
"To spare the foundation any negative effects as a result of controversy surrounding my cycling career, I will conclude my chairmanship," Armstrong said, according to the New York Times.
The evidence from the United States Anti-Doping Agency also caused Nike to drop its contract with Armstrong, the New York Times reported.
According to the Star Tribune, Nike said in a statement that it would continue to support Livestrong, but is dropping the contract with Armstrong because he "misled" the company for a decade.
Leave a comment